Emerald Health Therapeutics Promotes Two Executives to Senior Roles
Vancouver, British Columbia--(Newsfile Corp. - February 5, 2021) - Emerald Health Therapeutics, Inc. (TSXV: EMH) (OTCQX: EMHTF) ("Emerald") has promoted Orville Bovenschen to the position of Senior Vice President, Operations and Rebecca Wong to Senior Vice President, Quality & Regulatory Affairs.Mr. Bovenschen has over 16 years of progressive experience in financial management, project and operations management, and strategy development and operational planning, including risk management....
2021-02-05 7:00 AM EST
Emerald Health Therapeutics Settles Outstanding Amounts
Vancouver, British Columbia--(Newsfile Corp. - January 13, 2021) - Emerald Health Therapeutics, Inc. (TSXV: EMH) (OTCQX: EMHTF) ("Emerald") today announced that it has settled all outstanding amounts owing to the original vendors (the "Vendors") in connection with Emerald's 2018 acquisition of Verdélite Sciences, Inc. ("Verdélite Sciences") and Verdélite Property Holdings, Inc. ("Verdélite Property" and, together with Verdélite Sciences, the "Subsidiaries").The Subsidiaries were purchased by...
2021-01-13 7:00 AM EST
Emerald Health Therapeutics' Partner STENOCARE Makes First Delivery of Medical Cannabis Oil to Swedish Patients
Vancouver, British Columbia--(Newsfile Corp. - December 29, 2020) - Emerald Health Therapeutics, Inc. (TSXV: EMH) (OTCQX: EMHTF) ("Emerald") today announced that its partner, STENOCARE A/S, completed its first shipment and delivery of Emerald medical cannabis oil to patients in Sweden. In Sweden, several patients diagnosed with chronic nervous system pain, spasms and nausea from chemotherapy have via their doctor previously applied for a prescription for treatment with medical cannabis oil....
2020-12-29 7:00 AM EST
Emerald Health Therapeutics Introduces High Potency SYNC(TM) 100 CBD Oil
Vancouver, British Columbia--(Newsfile Corp. - December 17, 2020) - Emerald Health Therapeutics, Inc. (TSXV: EMH) (OTCQX: EMHTF) ("Emerald") has launched and made its first shipment of its new SYNC™ 100 CBD oil to the province of Saskatchewan. Shipments to Alberta and BC are scheduled for next week, with product expected to be available for purchase online and in licensed stores before the new year.This natural flavoured whole-flower cannabis oil is made with all-natural ingredients and...
2020-12-17 7:00 AM EST
Emerald Health Therapeutics Terminates Agreement for Sale of Quebec Cannabis Business
Vancouver, British Columbia--(Newsfile Corp. - December 4, 2020) - Emerald Health Therapeutics, Inc. (TSXV: EMH) (OTCQX: EMHTF) ("Emerald") today announced that it has terminated its share purchase agreement dated July 30, 2020 (the "Agreement") with Quinto Resources Inc. ("Quinto") in respect of the proposed sale of Emerald's wholly-owned subsidiaries, Verdélite Sciences, Inc. ("Verdélite Sciences") and Verdélite Property Holdings, Inc. ("Verdélite Property" and, together with Verdélite...
2020-12-04 5:02 PM EST
Emerald Health Therapeutics Reports Third Quarter 2020 Financial Results and Provides Corporate Update
Vancouver, British Columbia--(Newsfile Corp. - December 1, 2020) - Emerald Health Therapeutics, Inc. (TSXV: EMH) (OTCQX: EMHTF) ("Emerald") has released its financial results for the three and nine months ended September 30, 2020. Full versions of Emerald's unaudited condensed interim consolidated financial statements and management discussion and analysis can be found on SEDAR at www.sedar.com."The pivotal recent event for Emerald has been the completion of our divestment of our ownership...
2020-12-01 7:00 AM EST
Emerald Health Therapeutics Announces Full Prepayment of Convertible Debentures
Vancouver, British Columbia--(Newsfile Corp. - November 24, 2020) - Emerald Health Therapeutics, Inc. (TSXV: EMH) (OTCQX: EMHTF) (the "Company") has fully prepaid in cash all amounts owing under the convertible debentures issued to certain Canadian institutional accredited investors (the "Debentureholders") by the Company on September 9, 2019 (the "Convertible Debentures"). As a result, the Convertible Debentures are now terminated and the Company has no further obligations thereunder.The...
2020-11-24 7:00 AM EST
RETRANSMISSION: Emerald Health Therapeutics Completes Sale of Pure Sunfarms Interest and Achieves Pivotal Milestone in Transforming its Business
Vancouver, British Columbia--(Newsfile Corp. - November 2, 2020) - Emerald Health Therapeutics, Inc. (TSXV: EMH) (OTCQX: EMHTF) (the "Company") has completed the previously disclosed sale of its 41.3% interest in Pure Sunfarms Corp. ("PSF") to Village Farms International, Inc. ("Village Farms") (NASDAQ: VFF) (TSX: VFF) for consideration of $79,900,000.As previously announced by the Company, on September 8, 2020, it entered into a share purchase agreement (the "Share Purchase Agreement") with...
2020-11-02 9:11 AM EST
Emerald Health Therapeutics Completes Sale of Pure Sunfarms Interest & Achieves Pivotal Milestone in Transforming its Business
Vancouver, British Columbia--(Newsfile Corp. - November 2, 2020) - Emerald Health Therapeutics, Inc. (TSXV: EMH) (OTCQX: EMHTF) (the "Company") has completed the previously disclosed sale of its 41.3% interest in Pure Sunfarms Corp. ("PSF") to Village Farms International, Inc. ("Village Farms") (NASDAQ: VFF; TSX: VFF) for consideration of $79,900,000.As previously announced by the Company, on September 8, 2020, it entered into a share purchase agreement (the "Share Purchase Agreement") with...
2020-11-02 8:33 AM EST
Emerald Shareholders Vote in Favour of Sale of Pure Sunfarms
Vancouver, British Columbia--(Newsfile Corp. - October 29, 2020) - Emerald Health Therapeutics, Inc. (TSXV: EMH) (OTCQX: EMHTF) (the "Company") is pleased to announce that its shareholders have voted today at its annual general and special meeting (the "Meeting") to approve the sale of the Company's 41.3% interest in Pure Sunfarms Corp. ("PSF") to Village Farms International, Inc. ("Village Farms"). As previously announced by the Company, on September 8, 2020, it entered into a share purchase...
2020-10-29 2:10 PM EDT
Emerald Health Therapeutics Launches Flavoured Cannabis Oils, Expanding SYNC(TM) Product Line
Combination of appealing natural flavourings and terpenes offers unique consumer experienceEmerald also launches new SYNC CBD nanoemulsion-based Fast Action Spray in BC and SaskatchewanVancouver, British Columbia--(Newsfile Corp. - October 19, 2020) - Emerald Health Therapeutics, Inc. (TSXV: EMH) (OTCQX: EMHTF) ("Emerald") has expanded its SYNCTM product line with the launch of new uniquely flavoured CBD cannabis oil products. Emerald has made its first product shipments to British Columbia,...
2020-10-19 7:00 AM EDT
Emerald Health Therapeutics Receives Standard Processing License for Richmond, BC Greenhouse Facility
Vancouver, British Columbia--(Newsfile Corp. - October 13, 2020) - Emerald Health Therapeutics, Inc. (TSXV: EMH) (OTCQX: EMHTF) ("Emerald") has received a newly issued Standard Processing License (the "Processing License") from Health Canada for its 78,000 square foot organic-certified greenhouse facility in Richmond, BC.The Processing License expands on the site's existing cultivation licence to grow and produce bulk dried cannabis to now also permit the processing of consumer-ready dried...
2020-10-13 7:00 AM EDT
Emerald Health Therapeutics Closes Shares for Debt Transaction
Vancouver, British Columbia--(Newsfile Corp. - September 16, 2020) - Emerald Health Therapeutics, Inc. (TSXV: EMH) (OTCQX: EMHTF) (the "Company") has closed its previously announced shares for debt financing. Further to its news release dated August 21, 2020, the Company has settled $625,000 of debt (the "Debt") payable to the holders (the "Holders") of convertible debentures of the Company issued on September 10, 2019 (the "Convertible Debentures"). The Debt represents accrued interest on...
2020-09-16 7:47 PM EDT
Emerald Health Therapeutics and STENOCARE Receive Swedish Medicines Agency Approval to Provide Medical Cannabis Oil to Patients
Vancouver, British Columbia--(Newsfile Corp. - September 10, 2020) - Emerald Health Therapeutics, Inc. (TSXV: EMH) (OTCQX: EMHTF) ("Emerald") and STENOCARE A/S today announced that they have received special approval from the Swedish Medicines Agency to provide medical cannabis oil to Swedish patients who have applied via their doctor to use such products for treatment purposes.STENOCARE, located in Denmark, is a leading supplier of prescription-based medical cannabis products for patient...
2020-09-10 7:00 AM EDT
Emerald Health Therapeutics Enters into Share Purchase Agreement for Sale of Pure Sunfarms
Vancouver, British Columbia--(Newsfile Corp. - September 8, 2020) - Emerald Health Therapeutics, Inc. (TSXV: EMH) (OTCQX: EMHTF) (the "Company") is pleased to announce that it has entered into a share purchase agreement (the "Share Purchase Agreement") with Village Farms International, Inc. (NASDAQ: VFF) (TSX: VFF) ("Village Farms") in respect of the sale of the Company's interest in Pure Sunfarms Corp. ("PSF"), a joint venture that was established between the Company and Village Farms in...
2020-09-08 1:55 PM EDT
Emerald Health Therapeutics Reports Second Quarter 2020 Financial Results and Provides Corporate Update
Vancouver, British Columbia--(Newsfile Corp. - September 1, 2020) - Emerald Health Therapeutics, Inc. (TSXV: EMH) (OTCQX: EMHTF) ("Emerald") reported financial results for the three and six months ended June 30, 2020. Full versions of the Company's unaudited condensed interim consolidated financial statements and MD&A can be found on SEDAR at www.sedar.com."The second quarter was a very solid quarter in all aspects of our business. It marked a fundamental and notable shift in our financial...
2020-09-01 7:00 AM EDT
Emerald Health Therapeutics Launches New Fast-Acting Cannabis Spray Products Offering Consumers Significantly Improved Predictability and Control of Effects
Vancouver, British Columbia--(Newsfile Corp. - August 31, 2020) - Emerald Health Therapeutics, Inc. (TSXV: EMH) (OTCQX: EMHTF) ("Emerald") has launched the first product in its adult-use SYNCTM Nano fast-acting cannabis spray product line. SYNCTM 15 Nano THC Fast Action Spray allows consumers to choose ingestion over inhalation of cannabis while achieving a much more rapid, predictable onset and shorter controlled duration of effects compared to edibles and oils. The sublingual spray's...
2020-08-31 7:00 AM EDT
Emerald Health Therapeutics' Pure Sunfarms Joint Venture Begins Shipping Cannabis 2.0 Products and Bottled Oils
AM ETVancouver, British Columbia--(Newsfile Corp. - August 25, 2020) - Emerald Health Therapeutics, Inc. (TSXV: EMH) (OTCQX: EMHTF) ("Emerald") today announced its joint venture for large-scale, low-cost, high-quality cannabis production, Pure Sunfarms, has...
2020-08-25 7:00 AM EDT
Emerald Health Therapeutics Announces Shares for Debt Transaction
Vancouver, British Columbia--(Newsfile Corp. - August 21, 2020) - Emerald Health Therapeutics, Inc. (TSXV: EMH) (OTCQX: EMHTF) (the "Company") today announced that it has reached an agreement with the holders of convertible debentures of the Company issued on September 10, 2019 (the "Convertible Debentures") to settle accrued interest on the Convertible Debentures to June 30, 2020 in the amount of $625,000 by issuing an additional 3,571,428 common shares of the Company (the "Debt Shares") at...
2020-08-21 9:00 PM EDT
Emerald Health Therapeutics Reports Pure Sunfarms Second Quarter 2020 Financial Results
Vancouver, British Columbia--(Newsfile Corp. - August 13, 2020) - Emerald Health Therapeutics, Inc. (TSXV: EMH) (OTCQX: EMHTF) ("Emerald") has provided preliminary, unaudited financial results for the second quarter of 2020 for its 41.3%-owned joint venture, Pure Sunfarms."Pure Sunfarms' leadership in low-cost production enables it to offer consumers high-quality cannabis products that are well-priced. This strong competitive positioning against both licensed and unlicensed producers has...
2020-08-13 7:00 AM EDT